PartsTable TECHNICAL DATA SHEET
JULY 2026Technical Data Sheet

NDC00048-1040-05Levothyroxine Sodium Tablets

Baxter Healthcare Corp IV Systems/gov Sales · NSN 6505-01-094-1636 · FSC 6505 · No Item Name Available
Verified by PartsTable
NSN 6505-01-094-1636 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-094-1636. Primary manufacturer part number: NDC00048-1040-05.
Features
  • Levothyroxine Sodium Tablets — FSC 6505
  • Primary Container Content Quantity: 1000.000 TABLETS
  • Administration: ORAL
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Active Medicament Medicinal Strength: 0.050 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
  • Primary Container Type: BOTTLE
  • 4 verified cross-references
  • Primary manufacturer: Baxter Healthcare Corp IV Systems/gov Sales
Applications
  • Industrial maintenance and repair
  • Government and military logistics
  • Equipment overhaul and refurbishment
General Description

The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-094-1636, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Baxter Healthcare Corp IV Systems/gov Sales. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.

Technical Specifications
ParameterValue
NSN6505-01-094-1636
Primary Part NumberNDC00048-1040-05
Item NameLevothyroxine Sodium Tablets
FSC / FSG6505 / 65 — No Item Name Available
ManufacturerBaxter Healthcare Corp IV Systems/gov Sales
StatusACTIVE
Primary Container Content Quantity1000.000 TABLETS
AdministrationORAL
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Active Medicament Medicinal Strength0.050 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
Primary Container TypeBOTTLE
Lifecycle & Compliance
Acquisition StatusACTIVE
HAZMATNo
Verified Substitutes 12
6505-00-915-1630NDC00048-1140-03 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbott Laboratories Inc. Div Hospital Products Division
6505-00-990-2021 INTERCHANGEABLE
Levothyroxine Sodium Tablets
6505-01-042-9260NDC00074-6624-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-099-9794NDC00074-4341-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Inc
6505-01-153-3338NDC00378-1815-10 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Mylan Pharmaceuticals Inc
6505-01-153-4435NDC69238-1839-01 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Amneal Pharmaceuticals of New York, Llc
6505-01-178-3941NDC00048-1090-13 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-212-77183P1095 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-290-8735NDC00074-4552-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-323-4605NDC00074-7068-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
Cross-Reference Index
Part NumberManufacturer
NDC00048-1040-05 PRIMARY Baxter Healthcare Corp IV Systems/gov Sales (USA)
NDC00053-2541-04 Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc (USA)
SYNTHROID Baxter Healthcare Corp IV Systems/gov Sales (USA)
LEVOTHROID Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc (USA)
Related Parts
6505-00-915-1630INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1140-03
6505-00-990-2021INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
6505-01-042-9260INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-6624-19
6505-01-099-9794INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4341-19
6505-01-153-3338INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00378-1815-10
6505-01-153-4435INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC69238-1839-01
6505-01-178-3941INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1090-13
6505-01-212-7718INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
3P1095
6505-01-290-8735INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4552-19
6505-01-323-4605INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-7068-19
6505-01-351-0918INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1020-03
6505-01-366-0962INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-5182-19

Frequently Asked Questions

What is NSN 6505-01-094-1636?

NSN 6505-01-094-1636 is a Levothyroxine Sodium Tablets, manufactured by Baxter Healthcare Corp IV Systems/gov Sales, classified under FSC 6505 (No Item Name Available). Status: active.

What are the part numbers for NSN 6505-01-094-1636?

NSN 6505-01-094-1636 has 4 cross-referenced part numbers: NDC00048-1040-05 (Baxter Healthcare Corp IV Systems/gov Sales), NDC00053-2541-04 (Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc), SYNTHROID (Baxter Healthcare Corp IV Systems/gov Sales), LEVOTHROID (Armour Pharmaceutical Co Div of Rorer-Poulec Rorer Inc).

What NSN replaces 6505-01-094-1636?

There are 12 known substitutes for 6505-01-094-1636: 6505-00-915-1630, 6505-00-990-2021, 6505-01-042-9260 and 9 more. Verify interchangeability with system specifications before substitution.

What are the specifications of NDC00048-1040-05?

Key specifications for NDC00048-1040-05: Primary Container Content Quantity: 1000.000 TABLETS; Administration: ORAL; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Active Medicament Medicinal Strength: 0.050 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT. 5 total characteristics are documented in the Federal Logistics Information System.

Validated with multiple authoritative sources, including Government, OEM, and Certified sources.
PartsTable Design LLC · partstable.com